SIRT1 and neoplasm: First, in tumor cells, SIRT1 localizes to the promoters of TSGs, including E-cadherin, SFRPs, MLH1, and p27, that are aberrantly hypermethylated, leading to their transcriptional repression and subsequent unregulated cell proliferation [6].